Primary drug resistance rates in pulmonary tuberculosis

O. Deniz, F. Ciftci, E. Bozkanat, E. Demirer, M. Ozkan, I. Yuksekol, N. Ardic, K. Ekiz, N. Demirci (Istanbul, Ankara, Turkey)

Source: Annual Congress 2003 - Management and resistance features in tuberculosis
Session: Management and resistance features in tuberculosis
Session type: Poster Discussion
Number: 384
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Deniz, F. Ciftci, E. Bozkanat, E. Demirer, M. Ozkan, I. Yuksekol, N. Ardic, K. Ekiz, N. Demirci (Istanbul, Ankara, Turkey). Primary drug resistance rates in pulmonary tuberculosis. Eur Respir J 2003; 22: Suppl. 45, 384

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Primary drug resistance in pulmonary tuberculosis
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007


The ratios of primary and secondary drug resistance in pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 361s
Year: 2002

Characteristics of the cases with primary multidrug resistance pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 652s
Year: 2005

Pulmonary tuberculosis with primary drug resistant mycobacterium tuberculosis -treatment outcomes
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004

Primary drug resistance against mycobacterium tuberculosis in a high burden country
Source: Eur Respir J 2006; 28: Suppl. 50, 587s
Year: 2006

Primary and acquired drug resistance in childhood tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 653s
Year: 2005

Monitoring of drug resistance of TB mycobacteria in new pulmonary TB patients
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010

Development of mycobacterium tuberculosis additional drug resistance during chemotherapy of disseminated pulmonary tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 663s
Year: 2007

Treatment results in patients with drug resistant pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 612s
Year: 2002

Efficiency of standard chemotherapy of patients with pulmonary TB with relapses and treatment failure at drug resistance of M. tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 339s
Year: 2001

Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008


The peculiarities of course and treatment of pulmonary tuberculosis with initial drug resistance
Source: Eur Respir J 2003; 22: Suppl. 45, 41s
Year: 2003

Treatment of multidrug resistant pulmonary tuberculosis (MDR-TB) with different pattern of resistance
Source: Eur Respir J 2004; 24: Suppl. 48, 723s
Year: 2004

Isoniazid resistance is associated with delayed culture conversion during anti-tuberculosis treatment among patients with pulmonary tuberculosis
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018



Primary drug resistance of mycobacterium tuberculosis in HIV-positive patients
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016

Burden of the primary drug resistance of Mycobacterium tuberculosis in HIV-positive patients
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019

Clinical characteristic of the patients with drug resistant pulmonary tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 661s
Year: 2007

Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction
Source: Eur Respir Rev 2009; 18: 295-299
Year: 2009



Treatment results of multidrug resistant pulmonary tuberculosis (MDR-TB)
Source: Eur Respir J 2005; 26: Suppl. 49, 199s
Year: 2005

Secondary drug resistance tuberculosis in Iran
Source: Eur Respir J 2006; 28: Suppl. 50, 586s
Year: 2006